BORN2GROW unterstützt Biotech-Start-up Venneos bei weiterem Wachstum

Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells.

Weitere Infos